Quality data.

Only comes with quality endpoints. This look at the 214 oncology drugs approved by the FDA from 2006-2017 shows only 7 (3%) demonstrated clinically meaningful improvements in quality of life beyond other clinical endpoints at time of approval. | Arciero, JAMA Netw Open 2021

Comments

Popular Posts